128
Views
7
CrossRef citations to date
0
Altmetric
Reports

Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study

, , , ORCID Icon, ORCID Icon, , , , ORCID Icon, , & show all
Pages 2000-2003 | Received 14 Jul 2021, Accepted 23 Jul 2021, Published online: 11 Aug 2021

Reference

  • Balato N, Patruno C, Napolitano M, et al. Managing moderate-to-severe psoriasis in the elderly. Drugs Aging. 2014;31(4):233–238.
  • Grozdev IS, Van Voorhees AS, Gottlieb AB, et al. Psoriasis in the elderly: from the medical board of the national psoriasis foundation. J Am Acad Dermatol. 2011;65(3):537–545.
  • Boots AM, Maier AB, Stinissen P, et al. The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol. 2013;9(10):604–613.
  • Rowietz U, Altmeyer P, Bieber T, et al. Treatment of psoriasis with fumaric acid esters (fumaderm). J Dtsch Dermatol Ges. 2007;5(8):716–717.
  • Reich K, Thaci D, Mrowietz U, et al. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis-a retrospective study (FUTURE). J Dtsch Dermatol Ges. 2009;7(7):603–610.
  • Nast A, Gisondi P, Ormerod AD, et al. European S3-Guidelines on the systemic treatment of psoriasis vulgaris-Update 2015-Short version-EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015;29(12):2277–2294.
  • Available at: www.who.int/healthinfo/survey/ageingdefnolder/en
  • Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;2:1–70.
  • Zweegers J, de Jong EM, Nijsten TE, et al. Summary of the dutch S3-guidelines on the treatment of psoriasis 2011. Dutch society of dermatology and venereology. Dermatol Online J. 2014;20:doj_21769.
  • European Medicines Agency. Skilarence, INN-dimethyl fumarate: Summary of Product Characteristics. European Medicines Agency, London, 2017.
  • Thaci D, Weisenseel P, Philipp S, et al. Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions – a retrospective evaluation (FACTS). J Dtsch Dermatol Ges. 2013;11(5):429–435.
  • Kratzsch D, Treudler R. Dermatologic therapy in geriatric patients. J Dtsch Dermatol Ges. 2014;12(8):653–663.
  • Hoefnagel JJ, Thio HB, Willemze R, et al. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol. 2003;149(2):363–369.
  • Wain EM, Darling MI, Pleass RD, et al. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study. Br J Dermatol. 2010;162(2):427–434.
  • Lijnen R, Otters E, Balak D, et al. Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study. J Dermatol Treat. 2015;19:1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.